Mostrando 10 resultados de: 11
Filtros aplicados
Publisher
Nutrients(2)
Advances in Pharmacological Sciences(1)
Current Diabetes Reviews(1)
Current Pharmaceutical Design(1)
F1000Research(1)
Área temáticas
Enfermedades(8)
Farmacología y terapéutica(4)
Medicina y salud(2)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina forense; incidencia de enfermedades(1)
Anti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusDiabetes and Impaired Fasting Glucose Pbkp_rediction Using Anthropometric Indices in Adults from Maracaibo City, Venezuela
ArticleAbstract: To determine the pbkp_redictive power of various anthropometric indices for the identification of dyPalabras claves:diabetes mellitus, impaired fasting glucose, obesity, pbkp_rediction, RISK FACTORSAutores:Añez-Ramos R., Cabrera M., Calvo M.J., Chávez-Castillo M., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusDepression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
ReviewAbstract: Depression is currently recognized as a crucial problem in everyday clinical practice, in light of ePalabras claves:Autores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Valmore BermúdezFuentes:scopusNon-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusMetabolic syndrome: Is it time to add the central nervous system?
ReviewAbstract: Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central obesity, hypPalabras claves:Alzheimer’s disease, Diabetes mellitus type 2, Insulin Resistance, Metabolic syndrome, Mild cognitive impair-mentAutores:Añez-Ramos R., Chávez-Castillo M., Dávila L.C.A., Díaz-Camargo E.A., Durán-Agüero S., González M.C., Gravini-Donado M., Nava M., Parra H., Pírela D., Rina Ortiz, Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusMicrobiota and diabetes mellitus: Role of lipid mediators
ReviewAbstract: Diabetes Mellitus (DM) is an inflammatory clinical entity with different mechanisms involved in itsPalabras claves:DIABÉTES, dysbiosis, inflammation, lipopolysaccharides, microbiota, Short-chain fatty acidsAutores:Añez-Ramos R., Cano-Ponce C., Dávila L.C.A., González M.C., Martínez M.S., Morillo V., Navarro C., Rajotia A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore BermúdezFuentes:scopusPhysiologic Course of Female Reproductive Function: A Molecular Look into the Prologue of Life
ReviewAbstract: The genetic, endocrine, and metabolic mechanisms underlying female reproduction are numerous and sopPalabras claves:Autores:Calvo M.J., Chávez-Castillo M., Mejías J.C., Morillo J., Olivar L.C., Rojas M., Rojas-Quintero J., Valmore BermúdezFuentes:scopusLipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela
ArticleAbstract: Background. Visceral adiposity is related to insulin resistance (IR), a metabolic state considered aPalabras claves:Autores:Añez-Ramos R., Cano-Ponce C., Dávila L.C.A., Durán P., Fuenmayor J., González M.C., Nava M., Ortega A., Rivas-Montenegro A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusIs “leptin resistance” another key resistance to manage type 2 diabetes?
ReviewAbstract: Although novel pharmacological options for the treatment of type 2 diabetes mellitus (DM2) have beenPalabras claves:Adipokines, DIABÉTES, Hyperleptinemia, Insulin Resistance, leptin, Leptin resistance, obesityAutores:Chávez-Castillo M., Cristobal Ignacio Espinoza Díaz, Dávila L.C.A., D’marco L., González M.C., Herazo Y., Nava M., Ortega A., Pérez J.L., Rojas M., Rojas-Gómez D.M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:googlescopusPsycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy
ReviewAbstract: The placebo effect can be defined as the improvement of symptoms in a patient after the administratiPalabras claves:Analgesia, Cannabinoids, Conditioning, Depression, hormones, Opioid, Pain, Parkinson’s Disease, placebo effect, PsychoneuroimmunologyAutores:Ariza D., Chávez-Castillo M., Díaz-Camargo E.A., Galbán N., Medina-Ortiz O., Nava M., Ortega A., Riaño-Garzón M.E., Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopus